The Medical Service Department of SMC Pharma Division organized a series of online discussions focused on `Diagnosis and Management of Fever.' Chemists, as well as SMC's Blue Star and Green Star providers from different parts of the country, actively participated in these discussion sessions. The primary topics of conversation included various clinical aspects of fever, contemporary concerns relating to dengue, the role of antibiotics in fever management and the critical issue of antibiotic resistance. The providers enthusiastically took part in the question-and-answer (Q&A) segment in the concluding part of the sessions. They conveyed their gratitude for this knowledge sharing initiative and expressed their willingness to continue the same on a range of health-related topics. Notably, SMC Pharma achieved a significant milestone of revenue generation with its two products, Aziday (Azithromycin) and Prazomax (Omeprazole).

Source: Newsletter-46 (July-September), 2023